BOSTON & PERTH, Australia--(BUSINESS WIRE)--pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI):
* First R&D funding payments from Pfizer to commence
* BrachySil Pancreatic Cancer Study Results
* pSiNutria Business sold to Intrinsiq
pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI) today announced the filing of its Quarterly Cash Flow Statement for the quarter ended December 31, 2007 with the ASX.
